Chinese vitamin C makers off the hook for U.S. antitrust violations

Oct 19, 2016
Following a dismissal by a U.S. appeals court of a $147 million price-fixing judgment, Chinese lawyers say that the my-government-made-me-do-it antitrust defense may not work next time for PRC companies

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Last month, a three-judge panel of the U.S. Court of Appeals for the Second Circuit vacated a $147 million lower court verdict and freed a Chinese pharmaceutical maker from U.S. antitrust liability for price-fixing on the basis of international comity.

This premium content is reserved for
China Law & Practice Subscribers.

Benefits Include:

  • Unlimited access to site and digital newsletters
  • 5 free articles across the ALM subscription network every 30 days
  • Exclusive discounts on ALM events and publications

Continue reading by getting
started with a subscription.

Subscribe Now For Unlimited Access